SPN-820

· Navitor Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPN-820, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label of SPN-820 in Adults With Major Depressive Disorder [Phase 2]